The purpose of this study is to establish whether or not there is a clinical advantage to the use of Aquamantys® System from Medtronic Advanced Energy (formerly Salient Surgical Technologies) in patients undergoing primary total hip arthroplasty via the anterior supine intermuscular surgical approach in terms of blood loss, transfusion and wound healing. Wound healing will be assessed by a blinded observer and based upon a simple and subjective criteria: a) as expected, b) better than expected or c) worse than expected. The blinded observer is experienced in the care of the surgical patient and wound evaluation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Perioperative Change in Hemoglobin Level
Timeframe: From up to 30 days preoperative through postoperative day 1
Perioperative Blood Transfusion Requirement
Timeframe: From the beginning of surgical intervention to hospital discharge, which averages 2 days and may be up to 1 week postoperative
Perioperative Blood Loss
Timeframe: From beginning of surgical intervention through hospital discharge, which averages 2 days and may be up to 1 week